Intra-Cellular Therapies: Q3 Earnings Insights

Intra-Cellular Therapies ITCI reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM.

Here's what investors need to know about the announcement.

Intra-Cellular Therapies their estimated earnings by 3.26%, reporting an EPS of $-0.95 versus an estimate of $-0.92, which did not surprise analysts.

Revenue was up $14,838,000 from the same period last year.

Last quarter the company missed on EPS by $0.05, which was followed by a 8.8% drop in the share price the next day.

Here's a look at Intra-Cellular Therapies's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	-0.80	-0.80	-0.85	-1
EPS Actual	-0.85	-0.65	-0.76	-0.79
Revenue Estimate	19.44M	16.50M	11.84M	5.86M
Revenue Actual	20.05M	15.88M	12.45M	7.37M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Earnings Calendar